CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Guggenheim Adjusts PT on Regeneron Pharmaceuticals to $1,000 From $995, Maintains Buy Rating

Positive
AI Analysis

Summary

Guggenheim raised its price target on Regeneron Pharmaceuticals to $1,000 from $995 while maintaining a Buy rating.

Importance:2/10
Sentiment:
0.30
price_targetanalyst_ratingvaluation
Related Companies

Read the original article

Published by yahoo_finance on July 21, 2026 10:59 AM

Read Original